Development of Dendritic Cell-Based Immunotherapy Targeting Tumor Blood Vessels in a Mouse Model of Lung Metastasis-Reference-Cited by-同舟云学术

Development of Dendritic Cell-Based Immunotherapy Targeting Tumor Blood Vessels in a Mouse Model of Lung Metastasis

Published:2019-04-01 Issue:4 Volume:42 Page:645-648
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Nomura Tetsuya¹²,Yamakawa Makie¹,Shimaoka Takuto²,Hirai Takamasa¹,Koizumi Naoya¹,Maruyama Kazuo²,Utoguchi Naoki¹²

Affiliation:

1. Department of Pharmaceutics and Biopharmaceutics, Showa Pharmaceutical University

2. Faculty of Pharma-Sciences, Teikyo University

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/42/4/42_b18-00737/_pdf

Reference19 articles.

1. 1) Folkman J. What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst., 82, 4–6 (1990).

2. 2) Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature, 359, 843–845 (1992).

3. 3) Camussi G, Montrucchio G, Lupia E, Soldi R, Comoglio PM, Bussolino F. Angiogenesis induced in vivo by hepatocyte growth factor is mediated by platelet-activating factor synthesis from macrophages. J. Immunol., 158, 1302–1309 (1997).

4. 4) Danielsen T, Rofstad EK. VEGF, bFGF and EGF in the angiogenesis of human melanoma xenografts. Int. J. Cancer, 76, 836–841 (1998).

5. 5) Asahara T, Bauters C, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF, Isner JM. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation, 92 (Suppl.), II365–II371 (1995).

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A bibliometric analysis of the research landscape on vascular normalization in cancer;Heliyon;2024-04

2. Cellular microenvironment as an object of targeted therapy for malignant neoplasms;Advances in Molecular Oncology;2023-12-14

3. New advances in the research of clinical treatment and novel anticancer agents in tumor angiogenesis;Biomedicine & Pharmacotherapy;2023-07

4. Clusterin is a biomarker of breast cancer prognosis and correlated with immune microenvironment;Translational Cancer Research;2023-01

5. Tumor microenvironment complexity and therapeutic implications at a glance;Cell Communication and Signaling;2020-04-07